Chris Streather

Part of Sonic Healthcare Ltd., The Doctors Laboratory Ltd. is a British company that provides pathology services. The company is based in London, UK. The company was founded in 1987. David Anthony Byrne has been the CEO of the company since 1998. The Doctors Laboratory was acquired by Sonic Healthcare Ltd. on April 11, 2002 for $92.42 million.

Part of Sonic Healthcare Ltd., Sonic Healthcare Holding Co. functions as an investment holding British company. The company is based in London, UK. The company was founded in 2001. David Anthony Byrne has been the CEO of the company since 2004.

Part of Sonic Healthcare Ltd., TDL Genetics Ltd. is a British company that specializes in testing, diagnosis, and genetic counseling of inherited disorders. The company is based in London, UK.

UK General Insurance Group Ltd. 2 engages in the provision of insurance services. The firm offers bespoke personal lines niche insurance products coupled with a combination of expertise, people, systems and access to underwriting capacity. It also provides personal lines insurance products across the property, leisure and lifestyle, payment protection, financial loss, motor financial, warranty, travel and personal accident categories. The company is headquartered in Leeds, the United Kingdom.

NHS Improvement focuses on healthcare services. Its expertise lies in practical service improvement. It offers clinical redesign in cancer, diagnostics, heart, lung and stroke. The company was founded in 2008 and is headquartered in Leicester, the United kingdom.

Primary Group Ltd. is engaged in insurance and financial distribution activities. The company was founded in 1997 and is headquartered in Hamilton, Bermuda.

Part of Roper Technologies, Inc., Clinisys Solutions Ltd. is a British company that provides transformational technologies to laboratory managers, research scientists, and technicians. The company is based in Chertsey, UK and is part of the CliniSys Group, which is the market-leading provider of Order Communications software & LIMS in the UK & Europe. The company's services include capturing, analyzing, storing, and reporting test data, as well as providing verified and traceable data to evidence end-to-end lab workflow and processes, from sample creation through to final reporting.

Sonic Healthcare Benelux NV is a Belgian laboratory medicine services company founded in 2010. The private company operates in the Benelux region and provides various laboratory medicine services.

CIS Healthcare Ltd. provides the ChemoCare system, which is utilized by numerous NHS trusts to streamline prescribing and patient management. The private company is based in London, UK, and has subsidiaries in the United Kingdom. The system employs cutting-edge technology to ensure accessibility from anywhere at any time.

Mid-Atlantic Pathology Services, Inc. owns and operates dermatopathology laboratory. Its services include tissue processing, slide preparation, and interpretation, direct immunofluorescence testing and consultation. The company was founded on 1995 and is headquartered in Sterling, VA.

Sonic Healthcare USA, Inc. providing laboratory services to medical practitioners, hospitals. The company was founded in 2005 and is headquartered in Austin, TX.

Douglass Hanly Moir Pathology Pty Ltd. engages in offering pathology services for clinicians and healthcare professionals, private hospitals and nursing homes. The company was founded in 1996 and is headquartered in New South Wales, AU.

Sonic Clinical Services Pty Ltd. provides general practice management services. It manages medical centers for independent general practitioners. It offers operations and practice management, finance and accounting services, quality and risk management, business development support, information technology infrastructure and support, human resources management, and property management. The company was founded in 1999 and is headquartered in Sydney, Australia.

Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million.